Grindeks enhances R&D co-operation with academia
This article was originally published in Scrip
Executive Summary
Latvia's largest pharmaceutical company Grindeks has enhanced its co-operation with the Institute of Organic Chemistry (IOS) of the Latvian academy of sciences where its leading product, the cardiovascular Mildronate (meldonium), was discovered and developed.